Drug-Related AIDS/HIV or Hepatitis C

An effort to repeal South Dakota's voter-approved medical marijuana law gets underway, the Red Lake Reservation sees the first legal recreational marijuana sales in Minnesota, and more.

Decriminalization bills are alive in Alabama and North Carolina, the Iowa Senate approves hemp, the FDA eases opioid prescribing rules, Ciudad Juarez sees a bloody weekend, and more.

There are some policy prescriptions that could lower that toll, but some other politically popular ones would likely increase it.

A California marijuana banking bill advances, a Colorado marijuana deliveries bill dies, opioid prescriptions are declining, Trump repeats false claims about the border wall and drug smuggling, and more.

Who knew governments could actually do good things in the realm of drug policy?

The man Trump will reportedly name to head the DEA has some racial profiling issues in his past, the Global Commission on Drugs issued recommendations on dealing with the opioid crisis, the 6th Circuit slaps down the DEA in an asset forfeiture case, and more.

The science and evidence base is there. What is needed is the political will, and a little care.

The CDC issues a damning report about drug policy and Hep C, the clock is ticking on the Vermont legalization bill as the governor ponders his choices, Michigan legalizers hit the streets with petitions for 2018, and more.

Nevada will soon see the first syringe vending machines in the country, the Colorado legislature responds to a threatened federal crackdown -- for better and worse -- Wisconsin Gov. Scott Walker is moving forward with plans to drug test Medicaid recipients, and more.